Patent classifications
A23V2250/712
NUTRITIONAL COMPOSITIONS, THEIR USE IN REDUCING METABOLIC STRESS AND METHOD OF REDUCING METABOLIC STRESS
The present invention concerns a nutritional composition, for example a synthetic nutritional composition, for use in reducing the metabolic stress. This composition is for use in mammals, preferably in humans, more preferably in infants. The nutritional composition comprises one or more medium chain fatty acid (MCFA) derivative or derivatives for use in reducing metabolic stress. Conditions and/or diseases associated to the metabolic disorders and/or imbalances in an infant are selected in the group consisting of neurological, growth and/or gut retarded development or abnormalities, hypoglycemia, hyperglycemia, hyperinsulinemia, hypertriglyceridemia. The infant is born preterm or with low-birthweight (LBW) or who experienced intra-uterine growth retardation (IUGR) or small for gestational age (SGA)).
NUTRITIONAL COMPOSITIONS, THEIR USE IN REDUCING METABOLIC STRESS AND METHOD OF REDUCING METABOLIC STRESS
The present invention concerns a nutritional composition, for example a synthetic nutritional composition, for use in reducing the metabolic stress. This composition is for use in mammals, preferably in humans, more preferably in infants. The nutritional composition comprises one or more medium chain fatty acid (MCFA) derivative or derivatives for use in reducing metabolic stress. Conditions and/or diseases associated to the metabolic disorders and/or imbalances in an infant are selected in the group consisting of neurological, growth and/or gut retarded development or abnormalities, hypoglycemia, hyperglycemia, hyperinsulinemia, hypertriglyceridemia. The infant is born preterm or with low-birthweight (LBW) or who experienced intra-uterine growth retardation (IUGR) or small for gestational age (SGA)).
Nutritional formulations and kits for bariatric individuals
The present technology relates to a nutritional formulation for administration to bariatric individuals. The nutritional formulation includes a multi-nutrients dosage unit; and a minerals dosage unit.
Pulverulent carotenoid preparation for colouring drinks
The present invention relates to pulverulent compositions of at least one carotenoid selected from the group consisting of β-carotene, astaxanthin, canthaxanthin, citranaxanthin, lycopene and lutein, a process for the production of these pulverulent compositions, and the use of the pulverulent compositions.
Pulverulent carotenoid preparation for colouring drinks
The present invention relates to pulverulent compositions of at least one carotenoid selected from the group consisting of β-carotene, astaxanthin, canthaxanthin, citranaxanthin, lycopene and lutein, a process for the production of these pulverulent compositions, and the use of the pulverulent compositions.
METHOD OF PRODUCING ANIMAL FAT SAUCE BY EMULSION WITH A HIGH-SHEAR MIXER
Producing sauce (e.g., mayonnaise) using animal fat on a commercial scale to obtain the quantity, quality, and life of traditional commercial-grade sauce made with common fruit, nut, seed, flower, and vegetable oils. An industrial-grade emulsifying machine such as a high-shear mixer is utilized to ensure that the animal fat particles are made sufficiently small to produce a good emulsion. An anti-rancidity or antioxidant (e.g., vitamin E, rosemary oil extract (ROE), bovine casein hydrolysate (BCH)) is utilized to prevent the animal fat from becoming rancid and enabling longer shelf life. The animal fat offers many benefits over traditional fruit, flower, nut, vegetable, and seed oils including being cheaper and more plentiful commercially, better-tasting and health benefits, including anti-carcinogenic properties.
Obtention of a solution from extracts of <i>Rosmarinus officinalis </i>L. for use as a food coating
A process to obtain a semi-solid solution to be used as a food coating, obtained from extracts of rosemary and other antioxidant components is disclosed. This process shows various advantages, namely, the obtention of the rosemary extract, which main components are rosmarinic and carnosic acid, and carnosol, are obtained easily without the use of polluting solvents, and showing a good yield and a strong antioxidant capacity. The coating solution has few ingredients and all of them are harmless to human health, beyond being cheap and easy to obtain, allowing the preservation of food in a natural way, without needing additional processing or plastics, in line with many studies that refer this tendency in consumers.
Obtention of a solution from extracts of <i>Rosmarinus officinalis </i>L. for use as a food coating
A process to obtain a semi-solid solution to be used as a food coating, obtained from extracts of rosemary and other antioxidant components is disclosed. This process shows various advantages, namely, the obtention of the rosemary extract, which main components are rosmarinic and carnosic acid, and carnosol, are obtained easily without the use of polluting solvents, and showing a good yield and a strong antioxidant capacity. The coating solution has few ingredients and all of them are harmless to human health, beyond being cheap and easy to obtain, allowing the preservation of food in a natural way, without needing additional processing or plastics, in line with many studies that refer this tendency in consumers.
Zeaxanthin Formulations With Additional Ocular-Active Nutrients, For Protecting Eye Health And Treating Eye Disorders
Oral formulations for promoting eye health, and in particular for preventing or treating macular degeneration, are disclosed, containing zeaxanthin, a carotenoid pigment, and at least two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate the production of glutathione. Processes are disclosed for identifying ocular-active nutrients that will interact in a synergistic and potentiating manner with zeaxanthin, to provide better and more effective protection, for eye health, than can be provided by zeaxanthin alone. Additional optional agents include zinc, vitamin E, and vitamin C.
Zeaxanthin Formulations With Additional Ocular-Active Nutrients, For Protecting Eye Health And Treating Eye Disorders
Oral formulations for promoting eye health, and in particular for preventing or treating macular degeneration, are disclosed, containing zeaxanthin, a carotenoid pigment, and at least two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate the production of glutathione. Processes are disclosed for identifying ocular-active nutrients that will interact in a synergistic and potentiating manner with zeaxanthin, to provide better and more effective protection, for eye health, than can be provided by zeaxanthin alone. Additional optional agents include zinc, vitamin E, and vitamin C.